Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rare disease biotech Rallybio sets terms for $81 million IPO

firstwordpharmaJuly 23, 2021

Tag: Rallybio , IPO , RLYB211

PharmaSources Customer Service